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Antigen-specific, T  cell-derived factors have been the subject of extensive studies as 
possible  mediators  of immunoregulatory  interactions  (reviewed  in  references  1-3). 
Functionally,  two kinds of factor, helper and suppressor, can be distinguished.  The 
suppressor  factors  (TsF),  x again,  fall  into  two  categories,  namely,  inducer  factors 
(TsiF)  that  play  a  role  in  communication  between  T  cell  sets  of the  suppressor 
pathway,  and  effector factors  (TseF)  that  cause ultimate  suppression.  Because  the 
immune response to a single antigen may involve a multitude of regulatory factors, it 
is mandatory to establish a  pure source of these mediators for further biological and 
biochemical studies. To this end, several laboratories have produced T  cell lines or T 
cell hybridomas that secrete monoclonal TsF. While the role of some of these TsF in 
the suppressor pathway has not yet been determined  (4-6), other factors have been 
shown to possess TsiF (7, 8) or TseF (9-13)  activity. Thus, there exists now a battery 
of  monoclonal  TsF  suitable  to  study  cellular  interactions  in  different  suppressor 
pathways. However, there are other obstacles to these studies, namely, that the cells 
participating in most known suppressor pathways have not been identified,  and the 
effector functions used as a readout of suppression themselves involve complex cellular 
interactions  (4-6, 9-14). 
We have characterized recently a  suppressor pathway that regulates the immune 
response to lactate dehydrogenase B  (LDHB)  (15-17).  The suppressor effector (Tse) 
cell in this system is an Lyt-l+2  + cell that becomes activated by the recognition of 
LDHB together with E k  k  k  (E~Ep)  molecules of antigen-presenting cells (APC)  and' by 
an  additional,  nonspecific,  Tsi  cell-derived  signal.  The  target  of the  Tse  cell  is  a 
proliferating Lyt-1+2  - cell that recognizes LDHB together with the A (A~A~) molecules 
of the APC. The latter ceils probably include the LDHa-specific T  helper (Th) cells, 
since the strain distribution of responsiveness to LDHB is identical in terms of both T 
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cell proliferation and antibody production (15,  18). The interaction between Tse and 
Th  is  antigen-specific  and  major  histocompatibility  complex  (Mhc)-restricted,  and 
the  suppression  is  manifested  in  the  inhibition  of the  LDHB-specific,  A-restricted 
proliferation  of the  Th  cells.  Because  it  is  so  well  characterized,  the  anti-LDHn 
response provides an ideal system to study the mechanism of Tse-Th cell interaction. 
We report here the functional characterization of monoclonal TseF secreted consti- 
tutively  by  T  cell  hybridomas.  The  latter  were  produced  by  fusing  a  long-term, 
LDHB-specific Tse cell line with the BW5147 thymoma. We use this factor to clarify 
the mechanism of Tse-Th cell interaction. 
Materials  and Methods 
Mice.  8-15-wk-old male and female mice were obtained from our colony at the Max Planck 
Institute for Biology. The strains and their alleles  at 1-1-2 loci are listed in Tables IV and VI. 
Antigens and Immunization.  LDHB (LDH-H4 from pig heart; Boehringer, Mannheim, FR.G.), 
keyhole limpet hemocyanin (KLH; Calbiochem, Giessen,  F.R.G.), poly(gluS°alaa°tyr 1°) (GAT; 
Miles-Yeda,  Rehovoth,  Israel)  and  UPC  10  (purified  IgGz~ myeloma  protein;  Bionetics, 
Fresenius,  Stuttgart,  F.R.G.)  were emulsified  at  1/1  (vol/vol) ratio with  complete Freund's 
adjuvant  (CFA; Difco Hedinger, Stuttgart,  F.R.G.), and 0.05  ml of the emulsion, containing 
0.05 mg of antigen, was injected into mice subcutaneously, at the tail base.  Concanavalin A 
(Con A) was purchased from Deutsche Wellcome (Burgwedel, F.R.G.). 
Monoclonal Antibodies.  Monoclonal A- and E-specific antibodies secreted by hybridomas B 15- 
124R1  (anti-Ia.m2),  13/4 (anti°Ia.m7; reference 19; the cell lines were obtained from Dr. G. J. 
H~immerling, German  Cancer Research  Center,  Heidelberg,  F.R.G.),  10.-2.16  (anti-Ia.ml7; 
reference 20; obtained from the Salk Institute, San Diego, CA), Y17 (anti-Ia.m44; reference 24; 
a gift from Dr. D. B. Murphy, Yale University School of Medicine Dept. of Pathology, New 
Haven,  CT),  and  25-9-17  (reacts  with  an  unassigned  A  b  determinant;  reference  22;  the 
hybridoma was obtained from Dr. D. H. Sachs, Transplantation Biology Section, Immunology 
Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD) were used in 
ascites form. Monoclonal antibodies 1L9, 2L2, and 14P, specific for a molecule controlled by a 
locus in the A~-Ep interval and selectively expressed by T  cells,  were produced as described 
previously (23). 
Production of Hybridomas Secreting LDHB-Specific  TseF.  Long-term Tse cell line was established 
from LDHB-immune lymph node-cells of B 10.A(2R)  (suppressed nonresponder) mice. The Lyt- 
1  +2  + set containing LDHB-specifie Tse was separated by positive selection of Lyt-1  +2  + and Lyt- 
1-2  + cells with a  monoclonal Lyt-2.2 specific antibody followed by the selection of Lyt-l+2  + 
cells with a monoelonal Lyt-1.2 specific antibody (17), and the cells (1 ×  10$/ml) were cultured 
in Alpha minimal essential medium (Gibco, BCK Biocuh-Chemie, Karlsruhe, F.R.G.) supple- 
mented with 10% FCS, antibiotics, L-glutamine, and 2-mercaptoethanol, in the presence of 15 
#g/ml LDHB and syngeneic, irradiated (3,300 R) spleen cells (2.5 ×  10e/ml) as feeder cells, for 
1 wk,  followed by another week of culture in the presence of antigen, feeder cells, and T  cell 
growth factor (TCGF; 48 h supemate of Con A-stimulated mouse spleen cells). After three such 
culture cycles, the cells were expanded by weekly restimulations with LDHB, TCGF, and feeder 
cells.  The cultured cells  were found to suppress  the LDHa-specific proliferation of Lyt-l+2  - 
cells in an antigen-specific and Mhc-restricted fashion. Cells of the 4-mo-old Tse line were fused 
with the BW5147 thymoma, and the hybridomas were selected using standard methods (4, 24). 
The hybridoma supernates were screened for suppression of the antlgen-specific proliferation of 
LDHB-primed syngeneie Lyt-I+2  -  cells. Six hybridomas (2RL-Ts-1 through 6) were found to 
secrete, in the absence of antigen, a suppressive material. Two of these hybridomas (2RL-Ts- 1 
and 5) were recloned (at a density of 0.3 cell/well). All clones tested were positive,  and secreted 
TsF that was functionally indistinguishable from that produced by uncloned lines. Therefore, 
in the experiments described here, supernates of cloned and uncloned hybridomas were used 
indiscriminately. 
Testing the Effect of TseF on Antigen-specific T  Cell Proliferation.  Immune lymph-node cells or 
the Lyt-l+2  -  fraction thereof (obtained by separation on anti-mouse IgG-coated dishes  after IKEZAWA ET AL.  1857 
TABLE  I 
Antigen-Specificity of TseF Produced by Hybridoma Cells 
Anti-LDHn  Anti-LDHn  Anti-KLH  Anti-GAT 
response*  response  response*  response* 
Source of  (B 10.AL,  B 10.A(2R),  B 10.A(2R),  B 10.A(2R), 
supematant*  Lyt- 1  +2-)  gyt- 1  +2-  unseparated  unseparated 
~t cpm  S.I.  A cpm  S.I.  A cpm  S.I.  •  cpm  S.I. 
BW5147  80,669  20.0.  55,338  13.8  14,002  6.2  8,521  4.3 
2RL-Ts-1  936  1.2  567  1.1  15,278  6.6  9,034  4.7 
2RL-Ts-2  933  1.2  3,735  1.3  20,651  6.5  12,025  4.0 
2RL-Ts-3  526  1.1  3,722  1.2  20,172  6.8  10,676  4.1 
2RL-Ts-4  -268  1.0  1,498  1.1  20,319  5.3  12,994  4.5 
2RL-Ts-5  2,134  1.4  457  1.0  19,036  6.6  11,605  5.0 
2RL-Ts-6  -406  1.0  1,987  1.1  21,045  5.2  11,934  3.8 
* Hybridoma supernates were added to cultures at a  1:4 final dilution. 
* Proliferation of 4 ×  105 primed T cells in the" presence of 15/~g/ml of LDHB, 10/~g/ml of KLH, or 50 
~g/ml of GAT. 
treatment with Lyt-2.2-specific antibody, as described in reference 17) were tested for antigen- 
specific response in a standard 3-d proliferation assay (25). Different dilutions of the TseF or of 
a control factor (supernate of the BW5147 line) were included in the same culture volume (0.2 
ml) and were present throughout the culture. Alternatively, the immune Lyt-l+2  -  cells were 
preincubated with  factors  at  predetermined dilutions at  37°C  for  6  h,  the  cells were  then 
washed and tested for proliferation in the 3-d assay. The cultures were set up in triplicate, and 
the results were expressed as A cpm (the difference ofcpm in cultures with and without antigen) 
and as stimulation index (S.I.; the ratio of cpm in cultures with and without antigen). 
Absorption of TseF.  1-mt aliquots of hybridoma supernatant diluted  to  1:4 or  1:10 with 
culture  medium,  were  incubated  for  1 h  on  ice  with  2-4  X  10  v cells  using different  cell 
populations as shown in Table IV. The cells were then centrifuged and the supernates were 
removed and tested for TseF activity by including them, at a final dilution of 1:20 or 1:40, into 
the 3-d proliferation cultures containing LDHB-primed Lyt-1+2  -  cells. 
T~psin  Treatment of Cells.  The  Lyt-l+2  -  fraction of LDHB-primed lymph-node cells was 
treated  with  trypsin  (2.5  mg/ml)  in the  presence of DNAse  I  (20/~g/ml)  according to  the 
method  described  previously  (26).  The  recovered  cells  were  washed  three  times,  cultured 
overnight in a  medium containing 25% TCGF, and tested  for functional activity in the 3-d 
proliferation assay, with or without previous exposure (6 h) to TseF. 
Generation of Allorestricted T Cells.  T  cells recognizing antigen in the context of allogeneic A 
molecules were generated by in vitro priming to LDHB on allogeneie APC, after the removal 
of alloreactive cells with 5-bromo-2'-deoxyuridine and light treatment. Here we used a recently 
described  2 modification of the original method (27). 
Results 
The  Effect  of  Hybridoma-produced  TseF  on  Th  Cells  is  Antigen-specific  and  Mhc- 
Restricted.  Hybridoma  supernates,  when  included  in  the  3-d  proliferation  assay, 
inhibited  to  background  levels  the  response  of LDHB-primed  Lyt-l+2  -  cells  from 
B 10.AL and B 10.A(2R)  mice (unseparated cells from these strains are nonresponders 
to LDHB because of the presence of Lyt-1+2  + Tse cells; references 15-17), but did not 
influence the proliferative response of KLH-primed  and GAT-primed B 10.A(2R) cells 
(Table I). Thus the suppressive effect of these factors is antigen-specific. However, the 
LDHs-specific TseF completely suppressed the proliferative response of T  ceils to the 
2 Baxevanis, G. N., Z. A. Nagy, and J. Klein. 1983. The nature of the interaction between suppressor 
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TABLE  II 
Cross-Suppression of lgG~-Specific  T-cell Proliferation by the LDHB-Specific 
TseF 
Proliferative response of Th cells (Lyt-1 +2-) from 
B10.A (4R) mice primed to UPC 10 
Source of superna-  Anti-UPC 10  Anti-LDHB 
tant*  response*  response  t 
A cpm  S.I.  A cpm  S.l. 
--  330117  117.2  1320  1.5 
BW5147  308972  43.1  ND 
2RL-Ts-1  2287  1.3  ND 
* See footnotes to Table I. 
* Proliferation of 4 x  105 T  ceils in the presence of 125/Lg/ml of UPC 10 or 15 
isg/ml of LDHB. 
ND, not done. 
TABLE  III 
Time Course of Action of TseF on Th Cells 
Proliferative response of LDHB-primed  Proliferative response of GAT-primed 
Th cells (Lyt-l+2  -) after contact with  Th cells (Lyt-l+2 -) after contact with 
Preincuba-  2RL-TsF 1  *  2RL-TsF 1  * 
tion of Th 
cells with  Anti-LDHB  Con A  Anti-GAT  Con A 
TseF  response*  response*  response*  response* 
A cpm  S.I.  A cpm  S.I.  A cpm  S.I.  A cpm  S.I. 
0  78,851  (25.1)  126,195  (68.6)  15,748  (7.4)  138,986  (57.7) 
30 min  80,476  (39.3)  113,528  (55.1)  17,067  (6.6)  107,438  (36.2) 
1 h  92,667  (35.0)  114,597  (43.1)  15,366  (6.5)  110,571  (40.2) 
2 h  76,531  (34.0)  110,592  (48.7)  18,171  (8.3)  103,527  (42.2) 
4 h  125  (1.1)  105,389  (60.7)  15,003  (9.8)  102,832  (61.1) 
8 h  -235  (0.9)  107,019  (70.6)  16,142  (8.8)  103,7tl  (51.2) 
* Cells were  incubated  at  37°C  with  hybridoma  supernate  at  a  1:2  dilution,  washed,  and  tested  for 
proliferation. 
* The concentration of Con A was 25/zg/ml; LDHs and GAT were used at concentrations given in Table 
I. 
IgG2.  myeloma  protein  UPC  10  (Table  II).  This  finding  confirms  our  previous 
observation that  the Tse cells involved in  the  anti-LDHB and anti-IgG2, responses 
cross-react completely (28).  The crude hybridoma supernates caused complete sup- 
pression of T  cell proliferation at a dilution up to more than  1:500 (data not shown). 
The data in Table III demonstrate that  a  short  term  (4  h)  exposure of cells to the 
factor is sufficient to cause complete suppression, indicating that the factor is a TseF 
that acts directly on the Th cells. The interaction of TseF with Th is Mhc-restricted 
(Table IV). The strains used as Th donors map this restriction to the A,-E~ interval, 
and excludes the involvement of all other H-2 regions (also theJ region), and of non- 
H-2 genes.  Since the action of the LDHB-specific Tse cells on Th cells is also short- 
term, antigen-specific, and A-restricted, the hybridoma TseF can be considered as the 
secreted form of the molecule responsible for the Tse-Th cell interaction. 
Mhc-Restricted Absorption of TseF Activity with LDHn-Specific  Th Cells.  The suppres- IKEZAWA ET AL.  1859 
TABLE  IV 
H-2 Mapping of TseF Restriction 
LDHa-primed Th Cells 





Proliferative response of Th cells (Lyt- 1  +2-) treated with:* 
BW5147  2RL-Ts- 1  2RL-Ts-2  2RL-Ts-5 
A cpm  (S.I.)  A cpm  (S.I.)  A cpm  (S.I.)  A cpm  (S.I.) 
B10.A(2R)  k  k  k  k  b 
B10.A(4R)  k  k  b  b  b 
B10.A(5R)  b  b  k  k  d 
B10.A(3R)  b  b  b  k  d 
B10.S(9R)  s  s  k  k  d 
B10.MBR  b  k  k  k  q 
B 10.AQR  q  k  k  k  d 
C57BL/6  b  b  b  b  b 
CBA  k  k  k  k  k 
155,412  (15.1)  -1  (1.0)  -2,163  (0.9)  1,471  (1.1) 
130,368  (48.2)  --32  (1.0)  802  (1.2)  568  (1.1) 
123,249  (39.6)  115,453  (28.9)  127,165  (19.9)  110,223  (24.6) 
139,033  (12.5)  138,469  (12.6)  ND  137,574  (10.7) 
142,147  (23.4)  121,319 (19.7)  ND  116,946  (14.8) 
134,185  (61.4)  -91  (1.0)  421  (1.1)  381  (1.1) 
122,624  (17.7)  -718  (0.9)  ND  698  (1.I) 
131,065  (28.7)  133,404  (26.5)  146,938  (16.3)  156,367  (25.2) 
303,645  (44.8)  2,535  (1.4)  2,809  (1.3)  1,494  (1.2) 
* The TseF was added to cultures at a final dilution of 1:20. 
ND, Not done. 
TABLE  V 
Absorption of TseF with Antigen-Specific Th Cells 
Source of superna-  Absorbing cells* 
tam 
Proliferative response of Th 
(Lyt-l+2) cells to LDHB 
Strain  A cpm  S.I. 
BW5147  None  B10.AL  59,792  29.2 
2RL-Ts-5  None  B 10.AL  329  1.1 
2RL-Ts-5  LDHB-Primed syngeneic Lyt-l+2  -  B10.AL  57,581  22.1 
2RL-Ts-5  CAT-Primed syngeneic Lyt- 1  +2-  B 10.AL  103  1.0 
BW5147  None  B10.TL  166,071  14.3 
2RL-Ts- 1  None  B 10.TL  - 59  1.0 
2RL-Ts-1  LDHB-Primed syngeneic Lyt-l+2  -  B10.TL  150,383  12.5 
2RL-Ts-1  LDHB-Primed syngeneic Lyt-1+2 +, 
Lyt- 1-2 +  B 10.TL  511  1.0 
BW5147  None  B 10.AQR  115,704  17.7 
2RL-Ts-5  None  B 10.AQR  698  1.1 
2RL-Ts-5  Unprimed B10.A(2R)  spleen cells  B10.AQR  -962  0.9 
2RL-Ts-5  LDHB-Pulsed B10.A(2R)  spleen cells  B10.AQR  74  1.0 
2RL-Ts-5  Unprirned B10.A(4R)  spleen cells  B10.AQR  767  1.1 
2RL-Ts-5  LDHn-Pulsed B 10.A(4R) spleen cells  B 10.AQR  205  1.0 
* 1 ml of TseF diluted 1:4 or 1:10 was absorbed with 4 ×  107 and 2 ×  107 cells, respectively. 
sive activity of hybridoma  supernates  can be removed completely by absorption  with 
LDHB-primed  syngeneic [B 10.A(2R)]  Lyt-1+2 -  cells (Table V). In contrast, syngeneic 
Lyt-2-bearing cells primed  to LDHB, or syngeneic Lyt-l+2  -  cells primed  to CAT  do 
not absorb the factor. Similarly, LDHn-pulsed  or unpulsed spleen cells from unprimed 
syngeneic mice are unable  to  absorb  the  factor.  Thus  the TseF binds  to  the cells on 
which  it  acts  (LDHB-specific  Th  cells),  but  fails  to  bind  to  LDHB-primed  non-Th 
cells, to Th  cells of irrelevant specificity, or to APC. The  binding of TseF to Th  cells 
is subject to the same genetic restriction as its functional activity, that  is, the factor is 
only absorbed  by LDHB-primed  Th  cells that  share genes in the A,~-Ea interval with 1860  SUPPRESSOR  FACTOR SPECIFIC FOR  LACTATE DEHYDROGENASE  B 
TABLE VI 
Ak-Restricted Absorption of TseF with Th Cells 
Source of TseF 
Absorbing LDHB-primed 
Lyt-  1  +2- cells* 
Proliferative response of Th 
(Lyt-t+2  -) cells 
Alleles at 
Strain  H-2  Strain  A cpm  S.I. 
regions 
KAJED 
2RL-Ts-I  --  --  B10.A(2R)  -314  1.0 
2RL-Ts-1  B10.A(2R)  k  k  k k  b  B10.A(2R)  52,166  5.2 
2RL-Ts-1  B10.A(4R)  k  k  b b b  B10.A(2R)  52,449  4.8 
2RL-Ts-1  B10.A(5R)  b  b k k  d  B10.A(2R)  722  1.1 
2RL-Ts-1  C57BL/6  b  b b b  b  B10.A(2R)  945  1.1 
2RL-Ts-I  CBA  k  k k k k  B10.A(2R)  51,589  4.5 
2RL-Ts-5  --  --  B 10.AQR  698  1.1 
2RL-Ts-5  A.TFR1  s  k k k f  B10.AQR  i06,074  11.5 
2RL-Ts-5  B10.S(9R)  s  s  k k d  B10.AQR  457  1.1 
* 1 ml of 1:4 diluted TseF was absorbed with 2 ×  10  7 cells. 
the factor-producing cells (Table VI). Thus the factor acts after binding to its target 
cell in an antigen-specific and Mhc-restricted fashion. 
Antigen  Requirement of TseF-Th  Cell  Interaction.  The  antigen  specificity of TseF- 
binding  to  Th  cells  can  reflect  either  a  direct  receptor-receptor  interaction  (for 
example, idiotype-antiidiotype reaction) or an indirect interaction through an antigen 
bridge.  To  distinguish  between  these  possibilities,  we  tested  whether  antigen  is 
necessary for the TseF to act on Th cells. To conclusively demonstrate this point, one 
first has to ensure that the experimental system is devoid completely of antigen. This 
requirement  is  met  in  the  case  of the  TseF  used,  since  the  factor  is  secreted  by 
hybridomas  in  the  absence  of LDHB.  However,  the  Th  cells  might  have  carried 
LDHB, and so, to preclude this possibility we trypsinized them to remove the surface- 
bound  antigen.  Because  trypsin  also  attacks  cell-membrane proteins  (29),  the  cells 
were allowed to resynthesize their receptors during an overnight incubation in antigen- 
free medium. The interaction of these cells with TseF was then tested in a  short term 
(6  h)  culture,  with  or  without  LDHB.  The  cells were  then  washed,  and  tested  for 
antigen-specific proliferation. Suppression ensued during the 6-h exposure of Th cells 
to  TseF  only  when  antigen  was  added  to  the  system  (Table  VII).  Furthermore, 
trypsin-treated Th  cells regenerated their capacity to proliferate to LDHB  but  they 
were  unable  to  absorb  TseF  in  the  absence  of antigen  (Z.  Ikezawa,  unpublished 
results). We conclude, therefore, that an antigen-bridge is necessary for the TseF to 
bind to and act on Th cells. 
The Mechanism of Mhc-Restriction in the Interaction between TseF and Th Cells.  The data 
in Tables IV and VI have demonstrated that the TseF only suppresses Th cells that 
share  the  A~E  O interval  genes  with  the  factor-producing cells. We  have  previously 
shown that the same genetic restriction applies to the Tse-Th  cell interaction in the 
anti-LDHB response (17). Further analysis has revealed that the Tse-Th cell interac- 
tion is determined by the receptor of Th cells (anti-LDHB +  A k) and the presence of 
Ak-alleles in the genome of Tse cells.  2 We inferred from these data that the interaction 
is based on the recognition by Th cells of Ak-controlled determinants expressed on the IKEZAWA ET  AL.  1861 
TABLE VII 
Antigen Requirement in the TseF-Th Cell Interaction: LDHn-Primed 
B I O.A ( 4R )  Th ( Lyt- l+  2 -) Cells after T~ypsin Treatment and Overnight 
Incubation 
Short-term  (6 h) preincubation  with  Proliferative response to LDHB 
Supernatant*  LDHB*  A epm  S.I. 
BW5147 sup  -  158,776  25.1 
BW5147 sup  +  146,072  24.0 
2RL-TsF-  1  -  162,980  24.1 
2RL-TsF-  l  +  2,293  1.3 
* Cells were preincubated at 370C with hybridoma supernates at a 1:4 dilution, 
washed and tested for proliferation. 
15 btg/ml, when present. 
TABLE VIII 
Inhibition of TseF Activity by T Cell-specific Anti-A k Antibodies 
Pretrcatment of factors with anti- 
bodies (final dilution) 
Proliferative response of B 10.A(4R) 
Th ceils (Lyt-l+2 -) after 6 h incu- 
bation with 
BW5147 sup.*  2RL-TsF-5* 
/~ epm  (S.I.)  ~ cpm  (S.I.) 
--  --  296,704  (89.1)  190  (1.0) 
10.2.16:alarn. 17  (1:200)  148,377  (54.2)  189  (1.1) 
15.124.4:ala.m2  (1:200)  189,470  (56.1)  -45  (1.0) 
25.9.17:aA  b  (1:200)  237,411  (61.4)  684  (1.2) 
13.4:ala.m7  (h 1,000)  225,713 (64.0)  345  (1.1) 
Y17:ala.m44  (h 1,000)  218,754 (73.0)  646  (1.2) 
1L9:aAk-T  (1:800)  222,535  (75.5)  167,453 (53.6) 
14P:aAk-T  (1:800)  230,138  (69.9)  248,514 (68.4) 
* Hybridoma supernates were used at a 1:10 final dilution. 
Tse cells. If this hypothesis is valid, the TseF that exhibits identical genetic restriction 
to that of the Tse cell, must carry Ak-controlled antigenic determinants. We therefore 
tested whether Ak-specific monoclonal antibodies can abrogate the effect of TseF on 
Th cells. The factor was preincubated with the antibodies and then allowed to interact 
with LDHB-primed Lyt-1+2  -  cells for 6 h. The cells were then washed and tested for 
LDHe-specific proliferation in a  3-d assay. As shown in Table VIII, antibodies against 
the known  class II Mhc  molecules  (A and  E)  did not  interfere with  the activity of 
TseF. Interestingly, however, monoclonal antibodies IL9 and  14P that recognize A~- 
Ea  interval-controlled T-cell  specific determinants  (23)  completely neutralized  the 
TseF.  Another  antibody of the  T-cell-specific "anti-A  k'' series,  2L2,  had  the  same 
effect, whereas antibody  1G8 that  reacts with Tsi cells (T. Tada  et al., unpublished 
data)  had  no effect on  the TseF  (Z. Ikezawa, unpublished  results). Antibodies  1L9, 
2L2, and  14P, when  included in the assay cultures, neutralized the added TseF, but 
did not block the A~A~-restricted proliferation of Th cells (Table IX). Furthermore, 
the antibodies did not affect the capacity of Th cells to absorb the TseF (Z. Ikezawa, 
unpublished  data).  Thus,  the  antibodies recognize Ak-like determinants  carried by 
the factor, but absent from the APC and Th cells. We have investigated also whether 1862  SUPPRESSOR  FACTOR  SPECIFIC  FOR  LACTATE  DEHYDROGENASE  B 
TABLE  IX 
T-Cell Specific Anti-A k Antibodies Neutralize  TseF But Do Not Block 
Th Cell Proliferation 
Antibody 
added to cul-  BW5147 su-*p 
tures* 
Proliferative response of B 10.A(4R) Th (Lyt- 1  +2-) cells 
to LDHB in the presence of: 
2RL-TsF-I* 
A cpm  S.I.  A cpm  S.I. 
None  329,473  34.0  657  1.1 
1L9  227,318  20.1  138,255  13.3 
2L2  217,104  17.7  115,385  10.4 
14P  228,007  21.9  223,918  20.7 
* Final dilution 1:800. 
* Final dilution 1:40. 
TABLE  X 
The Interaction of TseF With Th Cells Is Determined by the Anti-A k Restriction Specificity of Th Cells 
Th (Lyt-l+2  -) cells  Proliferative response 
Supernatant  Monoclonal anti-  to LDHB  § 
Strain  Receptor specific-  added*  body added* 
ity  A cpm  S.I. 
CBA  LDHB +  A k  BW5147 sup  --  91,295  25.8 
CBA  LDHB at- A k  2RL-TsF-1  --  337  1.1 
CBA  LDHB +  A k  2RL-TsF- 1  1L9(aAk-T)  75,233  31.7 
CBA  LDHa .4- A k  2RL-TsF-1  14P(aAk-T)  81,538  33.9 
CBA  LDHa +  A  s  BW5147 sup  --  82,398  38.3 
CBA  LDHa +  A ~  2RL-TsF-1  --  94,446  49.0 
B10.S  LDHB +  A k  BW5147 sup  --  96,599  72.6 
B 10.S  LDHe +  A k  2RL-TsF- 1  --  -6  1.0 
B10.S  LDHB +  A  k  2RL-TsF-1  IL9(aAk-T)  55,593  31.7 
B10.S  LDHB +  A k  2RL-TsF-1  14P(~Ak-T)  75,607  44.4 
B10.S  LDHs +  A s  BW5147 sup  --  85,606  45.9 
B 10.S  LDHB +  A ~  2RL-TsF- 1  --  84,024  43.7 
* Final dilution 1:40. 
* Final dilution 1:800. 
§ Tested in the presence of the relevant APC (CBA and B10.S, respectively). 
the interaction  of Ak-like determinants  of the TseF with Th  cells depends  on the Mhc 
haplotype  or the receptor specificity of the Th  ceils. We  generated  in vitro CBA  (H- 
2 k)  and  B10.S  (H-Z)  Th  cells that  recognize  LDHB  in a  self-restricted manner  (A  k- 
and A~-restricted, respectively), or in the context of allogeneic A  molecules  (CBA anti- 
LDHB  +  A ~,  and  B10.S  anti-LDHB  +  Ak).  As  shown  in  Table  X,  the  Th  cells, 
irrespective of their Mhc  haplotype,  are suppressed by the factor, provided  that  they 
recognize LDHB  together with A k molecules. The  interaction  of Ak-like determinants 
of TseF with the anti-A k receptors of Th cells is abrogated  by the T-cell specific "anti- 
A k'' antibodies  1L9  and  14P.  Thus,  a  functionally  important  part  of the factor is an 
Ak-like  moiety,  which  binds  to  the  receptor  site  imposing  Ak-restriction  on  the 
recognition  of LDHB  by Th  cells. IKEZAWA ET AL.  1863 
Discussion 
In  this  communication  we  have  functionally characterized  a  monoclonal  TseF 
secreted constitutively by hybridomas that were made by fusing a long-term, LDHB- 
specific Tse cell line with the BW5147 thymoma. In terms of specificity and function, 
the  TseF is  equivalent  to  the  Tse cell itself (17),  and  can  thus  be considered the 
effector molecule of the latter. The factor consists of two functional parts, one that 
binds LDHB, and another that carries or mimics the A k determinant(s) recognized by 
the Th cells on the APC. For the suppression to occur, a double bond between TseF 
and  Th cell has  to be established,  that  is,  the TseF must  bind  to the anti-LDHB 
receptor of Th cells through an antigen bridge, and the Ak-like determinants of the 
factor must be bound by the anti-A  k receptor of the Th cell. (Whether the anti-LDHB 
and anti-A  k binding sites of Th cells are physically linked remains unknown.) When 
one of these  binding events  is  prevented from occurring by either the  removal of 
LDHB  from  the  system,  or  blocking  of the  Ak-like  moiety  with  antibodies,  no 
suppression occurs. The crucial role of Ak-like determinants in suppression has also 
been demonstrated by an independent line of evidence, namely by the observation 
that  LDHa-primed  T  cells  from  suppressed  nonresponder  strains  can  be  turned 
responder by including in the cultures any of the T-cell-specific monoclonal "anti- 
A k'' antibodies (23) used in this study (Z. Ikezawa et al., manuscript in preparation). 
The requirement for a  dual recognition explains the antigen-specificity and the A k- 
restriction of the interaction between the TseF (or the Tse cells)  and the Th cells  2 
(17). Once the TseF is bound to the Th cells, the suppression ensues within a matter 
of hours. 
Many of the suppressor factors characterized so far resemble the TseF described 
here, in that they possess a binding site specific for either the immunizing antigen (4- 
7, 9-13, 30, 31) or a receptor-idiotype of the target cell (8), and carry Mhc-controlled 
antigenic determinants (4-10,  12, 30, 31). The anti-antigen- or antiidiotype-binding 
site determines the factor-target cell interaction in all known suppressor systems. The 
Mhc determinants, in many but not all systems, impose a  genetic restriction on the 
factor-target cell interaction (4, 6-8,  12, 32). Thus, the interaction of these and some 
additional  factors  (33,  34)  with  their targets  appears  to  involve dual  recognition, 
similar  to the  LDHs-specific TseF.  One  important  difference between the  LDHB- 
specific TseF and all other known factors is that the former carries an A,~E~ interval- 
controlled moiety instead of determinants controlled by the so-called J  region. This 
fortunate situation permitted us to analyze the A-like moiety by comparison with its 
well-characterized, counterl~art  , the A~A~ cla~s II molecule. The data have demon- 
strated that there are determinants shared between APC-derived and TseF-derived A 
molecules, namely those that serve as restriction elements for antigen-recognition by 
Th cells. The factor-derived A-moiety carries additional determinants that are absent 
from APC  (or B  ceU)-derived A  molecules  (those recognized by the T  cell-specific 
monoclonal "anti-A  k'' antibodies), and lacks serologically detectable determinants of 
the  classical  A  molecule. Whether the  two  types of A  molecule are  controlled by 
different genes remains to be seen. Considering the relative paucity of class II genes 
in the A,~E~ interval (35), it is more likely that they represent different variants of a 
single  gene  product.  By analogy,  it  is  tempting  to  speculate  that  the  so-called .J 
molecule may be an analogous modification of another known class II gene product, 
perhaps the E~ chain. 1864  SUPPRESSOR  FACTOR SPECIFIC FOR LACTATE DEHYDROGENASE B 
Summary 
Hybridomas secreting a  monoclonal T  suppressor-effector factor (TseF) were pro- 
dueed by fusion of a lactate dehydrogenase B (LDHB)-specific long-term T suppressor- 
effector (Tse)  cell line with the BW5147 thymoma. A  short exposure (4  h)  to TseF 
completely suppresses  the  antigen-specific  and  A-restricted  proliferation  of LDHB- 
primed Lyt-l+2  -  [possibly helper (Th)] cells. The action of TseF on Th cells, as that 
of the Tse cells themselves, is  antigen-specific and  A-restricted.  The interaction  of 
TseF  with  Th  cells  involves  two  binding  events,  of which  one  occurs  via antigen 
bridge, and the other represents the recognition of a  factor-derived Ak-like moiety by 
the anti-A  k receptor of Th cells. The Ak-like moiety of the TseF carries the determi- 
nants  that  serve  as  restriction  elements  for  antigen  recognition  by  Th  cells,  and 
additional  determinants demonstrable by T  cell-specific monoclonal "anti-A  k'' anti- 
bodies, however, it lacks serologically detectable determinants  of the B  cell-derived 
A~At~ class II Mhc molecules. 
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